Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Cash & Equivalents: 2010-2025

Historic Cash & Equivalents for Solesence (SLSN) over the last 16 years, with Sep 2025 value amounting to $429,000.

  • Solesence's Cash & Equivalents fell 85.33% to $429,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $429,000, marking a year-over-year decrease of 85.33%. This contributed to the annual value of $1.4 million for FY2024, which is 18.18% down from last year.
  • Latest data reveals that Solesence reported Cash & Equivalents of $429,000 as of Q3 2025, which was down 89.56% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Solesence's Cash & Equivalents registered a high of $4.1 million during Q2 2025, and its lowest value of $429,000 during Q3 2025.
  • Over the past 3 years, Solesence's median Cash & Equivalents value was $1.8 million (recorded in 2025), while the average stood at $1.9 million.
  • As far as peak fluctuations go, Solesence's Cash & Equivalents surged by 232.72% in 2022, and later slumped by 85.33% in 2025.
  • Quarterly analysis of 5 years shows Solesence's Cash & Equivalents stood at $657,000 in 2021, then surged by 232.72% to $2.2 million in 2022, then dropped by 21.23% to $1.7 million in 2023, then declined by 18.18% to $1.4 million in 2024, then tumbled by 85.33% to $429,000 in 2025.
  • Its last three reported values are $429,000 in Q3 2025, $4.1 million for Q2 2025, and $1.8 million during Q1 2025.